Cargando…
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic
INTRODUCTION: Opioid use disorder (OUD) is a debilitating illness that remains a serious public health issue in the United States. Use of telemedicine to deliver medications for the treatment of OUD (MOUD) was limited until the confluence of the COVID-19 and opioid addiction epidemics in spring 2020...
Autores principales: | Mattocks, Kristin M., Moore, David T., Wischik, Dora Lendvai, Lazar, Christina M., Rosen, Marc I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949846/ https://www.ncbi.nlm.nih.gov/pubmed/35346533 http://dx.doi.org/10.1016/j.jsat.2022.108777 |
Ejemplares similares
-
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic
por: Wang, Linda, et al.
Publicado: (2021) -
Telemedicine in Neurology: Challenges and Opportunities
por: Al-Faraj, Abrar, et al.
Publicado: (2023) -
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges
por: Arunogiri, Shalini, et al.
Publicado: (2021) -
The pressing shortage of buprenorphine prescribers and the pending role of telemedicine
por: Molfenter, Todd
Publicado: (2015) -
Telemedicine in Care of Sarcoma Patients beyond the COVID-19 Pandemic: Challenges and Opportunities
por: Tsagkaris, Christos, et al.
Publicado: (2023)